Aurobindo Pharma

Indian multinational pharmaceutical company

Aurobindo Pharma ▸ Facts ▸ Comments ▸ News ▸ Videos

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

0 shares	Share Tweet Save Post Send

You Might Like

Delhi liquor 'scam': Kavitha threatened S C Reddy to pay money to AAP, CBI tells court The CBI disclosed that K Kavitha allegedly pressured Aurobindo Pharma promoter to pay Rs 25 crore to AAP for Delhi's excise zones, warning of business consequences. Kavitha is in CBI custody, accused.. IndiaTimes - Published on April 13, 2024
Atishi questions ED probe, says Kejriwal arrested based on one person's account Delhi minister Atishi Marlena of AAP alleged that CM Arvind Kejriwal's arrest stemmed from a statement by Aurobindo Pharma's owner, Sarath Chandra Reddy, who reportedly donated to BJP via electoral.. IndiaTimes - Published on March 23, 2024
BJP, BRS & Cong top recipients of donations from pharma firms BJP, BRS, Congress dominated pharma donations through electoral bonds, with BJP receiving the highest amount. Aurobindo Pharma, whose director was arrested in an excise scam, is also one of the donors.. IndiaTimes - Published on March 21, 2024

Aurobindo gets USFDA nod for generic version of Nasonex nasal spray IndiaTimes - Published on March 19, 2024
Aurobindo arm inks licence pact with Singapore's Hilleman for paediatric pentavalent vaccine candidate Aurobindo Pharma's subsidiary, Auro Vaccines Pvt Ltd said it has signed a license agreement with Hilleman Laboratories Singapore to develop and commercialize a paediatric pentavalent vaccine candidate... IndiaTimes - Published on September 27, 2023
Aurobindo gets licence to make generic version of Pfizer's oral antiviral Covid-19 pill nirmatrelvir Pharma major Aurobindo Pharma Limited has inked a sub-license agreement with the UN-backed Medicines Patent Pool (MPP) for manufacturing and supplying a generic version of Pfizer’s Covid-19 oral.. IndiaTimes - Published on March 17, 2022